MeSH tree: E05.478.550
Chimeric antigen receptor (CAR)-T cell therapy, which reprograms an individual's immune cells to seek out and destroy certain cancer cells, has revolutionized treatment for blood cancers such as lymphoma. But in some patients, ...
12 hours ago
0
2
In a phase 1 clinical trial, treatment with the investigational bispecific antibody cevostamab reduced cancer in more than 40% of patients with multiple myeloma, many of whom had already undergone multiple other cancer treatments, ...
Jul 22, 2026
0
7
A leading-edge immunotherapy may extend survival for patients with one of the most aggressive forms of blood cancer, according to newly published five-year results from a major clinical trial in the Blood Journal. The clinical ...
Jul 14, 2026
0
5
More children younger than 5 should be able to be vaccinated in pharmacies from January 2027 under a range of measures designed to boost vaccine coverage announced in this year's federal budget.
Jul 9, 2026
0
2
Public health relies on data—whether it is tracking the effectiveness of a given year's flu vaccine, monitoring blood lead levels around the country or estimating the prevalence of diabetes. These data form the basis for ...
Jul 8, 2026
0
5
Researchers at The University of Texas MD Anderson Cancer Center were able to eradicate measurable residual disease (MRD) in B-cell acute lymphoblastic leukemia (ALL) patients, a critical step in improving long-term survival ...
Jul 7, 2026
0
6
Researchers led by Universitätsmedizin Frankfurt and Goethe University Frankfurt have identified how particularly aggressive forms of lymphoma can be recognized. By combining genetic and proteomic analyses, the scientists ...
Jul 3, 2026
0
6
Every state, along with Washington, D.C., requires children to obtain certain vaccinations before they can attend school or childcare These mandates date back decades, and many public health experts consider them a foundational ...
Jun 29, 2026
0
4
Researchers at Weill Cornell Medicine, Cedars-Sinai Medical Center and Roswell Park Comprehensive Cancer Center have developed genetically engineered CAR T cells that specifically target and kill bladder cancer cells. The ...
Jun 26, 2026
0
6
Leading CAR T cell therapy researchers have developed a human-in-the-loop artificial intelligence (AI) framework that centers scientists' expertise to find viable target antigens for CAR T cell therapy. The work was led by ...
Jun 25, 2026
0
10
